Abbott实验室达到了收入预期,提高了2025年的指导意见,并增加了红利;积累了机构购买。 Abbott Labs met earnings expectations, raised 2025 guidance, and boosted dividend; stock up on institutional buying.

Abbott实验室报告说,第二季度收入为每股1.30美元,达到了预期水平,年收入增长6.9%,达到113.7亿美元。 Abbott Laboratories reported second-quarter earnings of $1.30 per share, meeting expectations, with revenue rising 6.9% year-over-year to $11.37 billion. 该公司将其2025年全年收入指导提高到每股5.12-5.18美元,并宣布季度红利为0.59美元,收益率为1.9%。 The company raised its full-year 2025 earnings guidance to $5.12–$5.18 per share and declared a quarterly dividend of $0.59, yielding 1.9%. 机构投资者,包括Geode Capital、Maple Capital和Baiard Inc.,增加了它们的股份,而PNC金融服务公司则减少了它的地位。 Institutional investors, including Geode Capital, Maple Capital, and Bailard Inc., increased their stakes, while PNC Financial Services reduced its position. 股票交易价格为126.98美元,市值为22208亿美元,共识"中等买入"评级,目标价147.00美元. The stock, trading at $126.98 with a market cap of $220.8 billion, has a consensus "Moderate Buy" rating and a target price of $147.00.